3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
1
Pheochromocytoma
1
Paraganglioma
1
Neoplasm Metastasis
1
Gastro-enteropancreatic neuroendocrine tumor
1
Interventions
Rituximab
4
Cyclophosphamide
4
ponatinib
2
Vorinostat
2
Vincristine
2
Prednisone
2
Etoposide
2
Doxorubicin
2
Brentuximab Vedotin
2
Bortezomib
2
tetulomab tetraxetan lu-177
1
pembrolizumab
1
ibrutinib
1
ibritumomab tiuxetan
1
fludarabine
1
durvalumab
1
cobomarsen
1
acalabrutinib
1
Melphalan
1
Lutetium
1
Lenalidomide
1
KW-2478
1
Imatinib Mesylate
1
Ifosfamide
1
Hsp90 inhibitor KU757
1
Cytarabine
1
Carmustine
1
Carboplatin
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Immune System Diseases
×
Lutetium-177
×
Clear all
No trials found.